Sponsored by Epicur Pharma® and Santgar™
*Please note: this recording is not approved for CE credits
This medical CE program provides veterinarians and veterinary technicians with advanced clinical training in emerging medical therapy for canine glaucoma and dry eye disease (DED/KCS). The course explores the interaction between intraocular pressure dynamics, ocular surface inflammation, and tear film integrity, with specific emphasis on the role of novel lipid-base ocular surface formulations used in conjunction with advanced tear replacers to promote long-term corneal health and visual function.
Describe the tear film structure and physiologic significance of the lipid layer in maintaining ocular surface stability and corneal protection.
Explain the pathophysiology of canine glaucoma and its interaction with ocular surface disease and treatment response.
Compare current medical glaucoma therapies and their indications, contraindications, and limitations.
Evaluate novel lipid-base ocular therapy platforms and their mechanism of action in supporting tear film stability and ocular surface repair.
Select appropriate treatment protocols for aqueous-deficient, evaporative, and mixed-mechanism dry eye disease.
Design long-term therapeutic plans combining glaucoma control, ocular surface stabilization, and monitoring strategies.
Dennis E. Brooks, DVM, PhD, DACVO
Board-certified by the American College of Veterinary Ophthalmologists (ACVO). Internationally recognized clinical ophthalmologist and academic leader with extensive research and teaching contributions.
Gustavo Adolfo García Sánchez, DVM, PhD, DACVO
Board-certified veterinary ophthalmologist with PhD-level research training and clinical expertise in neuro-ophthalmology, retinal disease, and translational ophthalmic therapy.
We have a full library of webinars and other resources to help you continue learning about the topics important to you, your practice, and your patients!